Passage Bio, Inc.PASGNASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank86
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-31.51M
↑ 56% vs avg
Percentile
P86
Within normal range
Streak
4 yr
Consecutive growthExpanding
Average
$-72.35M
Historical baseline
PeriodValueYoY Change
TTM$-31.51M+34.3%
2024$-47.99M+38.8%
2023$-78.41M+36.5%
2022$-123.48M+19.0%
2021$-152.52M-85.6%
2020$-82.17M-97.6%
2019$-41.59M-97.0%
2018$-21.11M-